GE HealthCare unveils Vivid ultrasound portfolio
Analysis based on 7 articles · First reported Aug 28, 2026 · Last updated Aug 28, 2026
The launch of new ultrasound systems is expected to strengthen GE HealthCare's position in the cardiovascular imaging market, potentially boosting sales and market share. The stock showed a slight pre-market increase of 0.55% following the announcement, indicating a mildly positive market reaction.
GE HealthCare announced three new cardiovascular ultrasound systems - Vivid Explorer, Vivid Advanced, and Vivid Focus - at the European Society of Endocrinology Congress 2026 in Germany — Munich, Germany. These systems join the ultra-premium Vivid Pioneer, broadening the Vivid family to four systems built on a common cSound software-based imaging architecture. Each system targets different care settings: Vivid Explorer for high-volume echo labs and interventional procedures, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems incorporate AI-enabled automation tools to streamline workflows and reduce manual steps. They also feature battery operation and power-saving modes. The systems are accompanied by EchoPAC Software Only v211 for offline analysis and reporting. All three systems and the software have received CE Mark in Europe and are pending U.S. FDA 510(k) clearance, not yet available for sale in the U.S. The products will be showcased at ESC 2026 from August 28-31.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard